Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page
- Check5 days agoChange DetectedAdded a link to the PHOENIX trial website that contains information about the trial and its participating centers. The sponsor attribution and related labeling were updated to list Biogen as sponsor and include a 'Helpful Links Provided by' note.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of v3.6.4, indicating a small administrative update to the ClinicalTrials.gov record.SummaryDifference0.0%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor update to the page’s documentation/versioning rather than a change to the study data itself.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3, signaling a small update to the study record metadata.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2. This indicates a newer version of the page's metadata rather than a substantive change to the study details.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded a notice that the study is no longer looking for participants, clarifying that recruitment has ceased and potential participants should not enroll. The update also adds user-facing guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and adjusts the Intervention/Treatment header formatting along with showing a new revision version (v3.6.0).SummaryDifference0.3%

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.